Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent

Copper diethyldithiocarbamate (Cu(DDC)(2)) is the active anticancer agent generated when disulfiram (DSF) is provided in the presence of copper. To date, research directed toward repurposing DSF as an anticancer drug has focused on administration of DSF and copper in combination, efforts that have p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Nanomedicine
Main Authors: Wehbe, Mohamed, Anantha, Malathi, Shi, Minghan, Leung, Ada Wai-yin, Dragowska, Wieslawa H, Sanche, Léon, Bally, Marcel B
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5459956/
https://ncbi.nlm.nih.gov/pubmed/28615941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S137347
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados